Marco Dotto work email
- Valid
Marco Dotto personal email
- Valid
Marco Dotto phone numbers
I’m a 4x founder and CEO, 4x business angel and 3x VC investor with 15+ years of experience in genomics, life sciences, longevity biotech and healthcare.I co-founded and managed as CEO the 1st genomics companies applying Next Generation Sequencing to provide:- Whole Genome Sequencing and genomic interpretation for rare disease diagnostics- DTC personalized genomics analysis based on WGS and WES- Non Invasive Prenatal Tests based on circulating cell-free fetal DNA sequencing- Multi-omics and liquid biopsy analyses for personalized cancer therapyto the Italian market.I have managed the start-up, scale-up & exit of several companies that have leveraged disruptive technologies to improve patients' health:- Personal Genomics (acquired by the multinational company SOL S.p.A.) - Biodiversa- Sorgente Oncologia- DNA ConsultingI have also managed the global scouting of startups and the strategic partnerships for Angelini Ventures, the Corporate Venture Capital fund of Angelini Industries, with 300 M € of AUM investing in disruptive digital health & life sciences startups.My personal and professional mission is to transform patients lives by making disruptive and transformative technologies accessible at a global scale. I worked on this mission as a startup and scale-up entrepreneur / CEO 1st, as a consultant for small and large US and EU companies and then as a VC and business angel getting experience on both the investor and entrepreneur sides.My genomics companies managed hundreds of clinical research and diagnostics projects in oncology, immunology, genetics, rare diseases and virology that led to hundreds of publications in top impact factor scientific journals. I have managed strategic partnerships globally connecting investors, talents, researchers, techologies and business experts.I’m focused on the tech scouting and scale up of the latest innovations to be the catalyst for impactful and exponential improvements that could reshape healthcare globally. I'm also a Limited Partner of 3 seed & series A Venture Capital funds (Unruly Capital, Eden Ventures, Moonstone).Unruly Capital is focused on disruptive deep techs: - Climate Tech: Energy, Electrification, FoodTech, Agriculture, Construction- Future Tech: Space, Synthetic Biology, New materials, AI- MedTech & Longevity: Drug discovery, MedTech, New compounds, Psychedelics, Genetic engineering, Biotech- Decentralization: Food & Energy production, 3D Printing, Recycling, Resilient supply chainsI also founded a syndicate of investors focused on longevity biotech
-
Chief Operating OfficerRubedo Life SciencesTreviso, It
-
Board MemberRubedo Life Sciences 2024 - PresentSunnyvale, California, Us
-
Angel InvestorRubedo Life Sciences 2024 - PresentSunnyvale, California, UsRubedo Life Sciences is a longevity biotech company developing a broad portfolio of innovative therapies engineered to target senescent cells which drive chronic age-related diseases and play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders.
-
Limited PartnerUnruly Capital 2022 - PresentLondon, GbPre-seed and seed VC fund dedicated to invest in disruptive technologies- Climate Tech: Energy (generation and storage), Electrification (transportation and industry), FoodTech, Agriculture, Construction ...- Future Tech: Space, Synthetic Biology, New materials, Artificial Intelligence- MedTech and Longevity: Drug discovery, MedTech, New compounds, Psychedelics, Genetic engineering, Biotech- Decentralization: Food & Energy production, 3D Printing, Recycling, Resilient supply chains -
Co-Founder And CeoBiodiversa S.R.L. Mar 2016 - PresentBiodiversa is a leading provider of end to end Next Generation Sequencing services and bioinformatics. It provides NGS services to researchers and clinicians including support to grant applications, research and clinical project design, samples logistics, sample extraction, library preparation, sequencing and bioinformatic analysis. Biodiversa has managed tens of thousands of samples and hundreds of NGS projects. It successfully helped and enabled hundreds of researchers and clinicians to do disruptive discoveries that have been published in the highest impact factor scientific and medical journals. -
Partner And Co-FounderBiodiversa S.R.L. May 2014 - Mar 2016
-
Angel InvestorNurture Genomics 2023 - PresentCambridge, Ma, UsNurture is the 1st clinical care platform to empower parents and pediatricians with proactive genomic insights for newborns and children.Bringing whole genome sequencing to newborns to help guide care and decision making for families. -
Limited PartnerMoonstone Venture Capital Apr 2023 - PresentMilan, Lombardy, It -
Limited PartnerEden Venture 2022 - PresentMilano, Milano, ItEden Venture is an international venture capital firm focused on pre-seed startups, backed by IAG, the main Italian business angel network. Our founders can leverage a 500+ angels network unlocking business connections and fundraising opportunities with club deals and VC partners. -
Angel InvestorSizable Energy 2022 - PresentMilan, Mi, ItDeveloping an innovative, low-cost, highly efficient, scalable energy storage solution based on offshore pumped-hydro storage system; a storage solution that is cheaper than batteries, less carbon-intensive, and effortlessly integrated with floating offshore wind farms.Our unique technology features a simple yet effective design, utilizing a reservoir on the ocean floor, one floating on the surface, a connecting pipe, and reversible pump-turbines. Gravitational potential energy storage is obtained by pumping upwards heavier than water saturated seasalt brine. This design allows us to expand the available deployment area for pumped hydro to all offshore locations between 300m and 2000m of depth, providing an unparalleled storage solution with zero land use and streamlined permitting.Sizable Energy is committed to creating a sustainable and reliable energy storage system that caters to the needs of large floating offshore wind parks and standalone large-scale plants. -
Angel InvestorItalian Angels For Growth 2021 - PresentMilan, Lombardy, ItItalian Angels for Growth (IAG) www.italianangels.net is the largest Angel Group in Italy and Member of Business Angels of Europe Confederation (BAE)IAG was founded in 2007 and now has 270+ members characterized by their passion and expertise for entrepreneurship, innovation and early stage financing.IAG's mission is to facilitate investments in early stage companies in Italy and abroad trough the presentation of selected investment opportunities to its members.IAG is deeply committed to promoting entrepreneurship as a mean to foster economic growth, to create new qualified jobs and help innovation to scale exploiting the best talent and ideas. -
Founder & CeoDna Consulting S.R.L. 2017 - PresentMilano, It -
Scientific Board MemberOpen Biomedical Initiative Apr 2016 - Presentwww.openbiomedical.org
-
Principal & Program Manager For Scouting And Strategic PartnershipsAngelini Ventures 2021 - 2022Rome, ItAngelini Ventures is the Corporate Venture Capital company of Angelini Industries, investing in international startups disrupting Healthcare: Life Sciences & Biotech, Digital Therapeutics & AI Health. -
Senior Business Development Consultant & Strategic PartnershipsHealth Catalyst May 2019 - 2021South Jordan, Utah, UsHealth Catalyst (Nasdaq:HCAT) is a leading provider of big-data and analytics technology and services to healthcare organizations, committed to being the catalyst for massive, measurable, data-informed healthcare improvement. -
Co-Founder And CeoSorgente Oncologia S.R.L. Sep 2016 - Dec 2019Bringing genomics to cancer patients for personalized medicine and care
-
Business Development ManagerSorgente Group Jun 2016 - Dec 2019Milano, Milano, Itwww.sorgentegenetica.it - www.sorgente.com -
Partner And CeoPersonal Genomics S.R.L. Mar 2013 - Apr 2016Verona, Veneto, ItPersonal Genomics is a leading company providing diagnostic and clinical research services focused on genomics, molecular biology, Next Generation Sequencing and bioinformatics.Under my management it was the first company in Italy providing whole genome sequencing services (coupled with bioinformatics and clinical geneticist board for interpretation) to help patients affected by unknown genetic diseases end their diagnostic odyssey.Personal Genomics brought to Italy the first Non Invasive Prenatal Test based on fetal DNA sequencing, a technique that then became the gold standard for prenatal aneuploidy screening globally. Personal Genomics has been involved in hundreds of research and clinical research projects processing tens of thousands of samples including the biggest genomics project in Italy focused on aging where hundreds of centenarians and ultra-centenarians have been whole genome sequenced.Personal Genomics has been granted several national and EU grants for clinical research projects. -
Business Developer - Ngs And Genomics Services' Sales SpecialistBmr Genomics Oct 2010 - Mar 2013Padova, Pd, ItAt BMR Genomics, the biggest DNA sequencing service italian provider, I was the technology specialist for the Next Generation Sequencing department and business developer of the genomics' division.I was involved in sales strategy development, new technologies' scouting, partnership agreements, key account management, and suppliers' management. -
Business And Service DeveloperBmr Genomics Apr 2009 - Oct 2010Padova, Pd, ItI developed an innovative DNA sequencing service that introduces the Next Generation DNA sequencing technologies into the personal genomics mass market for the first time.The service is focused on the identification of genetic disease causing mutations through high throughput DNA sequencing.I managed both the marketing, strategic and technological development of the project and brought it from the seed level to the market.
-
Contract Professor At University Of Padova - International Business DepartmentUniversity Of Padova Feb 2011 - May 2012Padova, Padova, ItI taught the " Complex Innovation Systems " english course (2011) and I am currently teaching the " Innovation Management " (2012) course for the postgraduate students of the Department of International Economics at the Univerisy of Padova. The courses are based on the theoretical and practical analysis of the key factors at the base of innovation and of the main characteristics of complex innovation systems.The courses are mainly focused on the analysis of case studies within the Biotech and other industries which are involved in innovative science and technology. -
Management Master Student - Mabit: Master In Management For The Biotech IndustryFondazione Cuoa - Business School Feb 2010 - Dec 2010Altavilla Vicentina, Vi, ItI was selected for a one year scholarship award to study at the CUOA Business School for a master in management specific for the Biotech sector.I developed my skills in management, business strategy, finance/accounting, project management, business planning, intellectual property, sales strategy and marketing. -
Graduate StudentUniversità Degli Studi Di Padova Oct 2008 - 2010Padova, Padova, ItI got my B.S. (Bachelor of Science) in BIOTECHNOLOGY in 2007 and then I graduated from my M.S. (Master of Science) in INDUSTRIAL BIOTECHNOLOGY in 2010 (110 cum laude). I am specialized in IMMUNOBIOTECHNOLOGY and RECOMBINANT PROTEINS PRODUCTION. I focused my thesis on NEXT GENERATION DNA SEQUENCING and developed a deep knowledge in GENOMICS and Next Generation DNA sequencing applied to the personal genomics market.
-
Biotech StudentUcsd Aug 2007 - Sep 2008I won a scholarship for the EAP - studying abroad program and studied at the University of California San Diego for a year. At the faculty of Bioengineering (2nd in the national ranks during 2008) I focused my studies on genomics and bioengineering and I also attended several classes of the Rady School of Management. I earned the Provost honor during all the quarters I studied at UCSD.
-
Undergraduate StudentUniversity Of Padova Oct 2004 - Jul 2007Padova, Padova, ItI graduated in BIOTECHNOLOGY
Marco Dotto Skills
Marco Dotto Education Details
-
Uc San DiegoBiotechnology -
Cuoa Business SchoolManagement
-
Università Degli Studi Di PadovaIndustrial Biotechnology: Functional Genomics And Proteomics
-
Università Degli Studi Di PadovaBiotechnology
-
Liceo Scientifico Leonardo DavinciScience
Frequently Asked Questions about Marco Dotto
What company does Marco Dotto work for?
Marco Dotto works for Rubedo Life Sciences
What is Marco Dotto's role at the current company?
Marco Dotto's current role is Chief Operating Officer.
What is Marco Dotto's email address?
Marco Dotto's email address is do****@****ail.com
What is Marco Dotto's direct phone number?
Marco Dotto's direct phone number is +3933876*****
What schools did Marco Dotto attend?
Marco Dotto attended Uc San Diego, Cuoa Business School, Università Degli Studi Di Padova, Università Degli Studi Di Padova, Liceo Scientifico Leonardo Davinci.
What skills is Marco Dotto known for?
Marco Dotto has skills like Genomics, Biotechnology, Genetics, Bioinformatics, Molecular Biology, Dna Sequencing, Life Sciences, Start Ups, Business Strategy, Science, Dna, Marketing Strategy.
Who are Marco Dotto's colleagues?
Marco Dotto's colleagues are Myojung Yang, Jeff Jasper, Alex Laslavic, Corrigan (Cory) Horton, David Hollenback, Phd, Shreya Satagopan.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial